Home › Trial NCT03681951
First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors
- Trial IDNCT03681951
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorGlaxoSmithKline
- Enrollment8
- Start date2018-11-16
- ConditionsNeoplasms, Pancreatic
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.